Showing results (521-530 of 601) with videos related to
Sort By:
Pageof 61
Frontiers in Oncology|August 28, 2020
Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell CarcinomasAndrew J Shih, Neal Murphy, Zachary Kozel, et al.Journal of Perinatal Medicine|October 30, 2021
Maternal oxytocin administration modulates gene expression in the brains of perinatal miceFrances F Hsieh, Ilya Korsunsky, Andrew J Shih, et al.Community Mental Health Journal|July 29, 2022
Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental IllnessDerjung M Tarn, Kevin J Shih, Allison J Ober, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
A phase 0 trial of riluzole in patients with resectable stage III and IV melanomaDana Yip, Maithao N Le, Joseph L-K Chan, et al.Statistics in Medicine|March 1, 1993
Monitoring of clinical trials and interim analyses from a drug sponsor's point of viewG W Williams, R L Davis, A J Getson, et al.Journal of Neurosurgery. Case Lessons|May 4, 2026
The minimally invasive grid approach for seizure localization: patient seriesMegana Saripella, Hayley A Granberg, Hernan Gonzalez, et al.Clinical Cardiology|June 15, 2021
Kidney outcomes using a sustained ≥40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trialsDavid Z I Cherney, Samuel Dagogo-Jack, Darren K McGuire, et al.The Journal of Vascular Access|May 11, 2021
Sono-angiography for dialysis vascular access based on the freehand 2D ultrasound scanningWilliam F Weitzel, Nirmala Rajaram, Venkataramu N Krishnamurthy, et al.Diabetologia|March 5, 2021
Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trialDavid Z I Cherney, Bernard Charbonnel, Francesco Cosentino, et al.Oncology Research|November 8, 2001
Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cellsX Zheng, R L Chang, X X Cui, et al.Pageof 61